FDA Recall Update on Certain Blood Glucose Meters

Important safety information for users of TRUE METRIX® blood glucose monitoring systems.

The U.S. Food and Drug Administration (FDA) has issued a Class I recall (the most serious type) affecting blood glucose monitoring systems sold under the TRUE METRIX® brand.1

What the Recall Involves

TRUE METRIX® meters display the same E-5 Error Code for two different issues:1

  1. A very high blood glucose event (> 600 mg/dL), and/or
  2. A test strip error.

This could lead to delayed treatment, incorrect treatment decisions, and potentially serious health risks.1

What the FDA Recommends1,2

The FDA recommends all TRUE METRIX® users transition to an alternative method of testing their blood glucose, when possible.
  • Review updated instructions for your meter.
  • Pay close attention to error messages and symptoms; if symptoms don’t match your reading, seek medical guidance immediately.
  • Speak with your healthcare provider or pharmacist about next steps — continue testing with your TRUE METRIX® meter until you secure an alternative.

Learn more from the FDA

Have Questions About Your Current Meter?

You’re not alone — many patients are exploring their options following this recall. Choosing a blood glucose monitoring system you can understand and trust is an important part of managing your health every day.

Make the Switch — CONTOUR®NEXT

A Trusted and Reliable Option for Managing Your Blood Glucose

CONTOUR®NEXT meters and test strips are designed to support simple and accurate blood glucose monitoring — so you can feel confident in your daily routine.

Why consumers choose CONTOUR®:

  • Highly accurate results in seconds3,4,5,6
  • Available without a prescription
  • Ordered online, delivered directly to your home
  • CONTOUR® users reported higher levels of satisfaction than TRUE METRIX® users7
  • Designed for a simple and seamless transition

GET STARTED WITH CONTOUR®NEXT

CONTOUR NEXT GEN Starter Kit

Always follow FDA guidance and consult your healthcare provider before making changes to your diabetes care. This page is intended for informational purposes and does not replace medical advice.

References
  1. U.S. Food and Drug Administration. Blood Glucose Monitor Recall: Trividia Health Issues Correction for TRUE METRIX® Blood Glucose Monitoring Systems. April 28, 2026. fda.gov
  2. U.S. Food and Drug Administration. Risks of Using TRUE METRIX® Blood Glucose Monitoring Systems by Trividia Health (Safety Communication). April 28, 2026. fda.gov
  3. Bernstein. et al. (2013). JDST. https://doi.org/10.1177/193229681300700531
  4. CONTOUR®NEXT GEN BGMS User Guide. Rev 03/25.
  5. Pleus, S. et al. (2022). https://doi.org/10.1177/19322968221141926
  6. Christiansen, M. P. (2017). JDST. DOI: 10.1177/1932296817691301
  7. Ascensia Diabetes Care. Data on File. FY26 Q1 Patient Panel Survey, DQ&A, 4/2026
© 2026 Ascensia Diabetes Care. All rights reserved.